|
[1]
|
Abe, R., et al. (1976) Biological Characteristics of Breast-Cancer in Obesity. Tohoku Journal of Experimental Medicine, 120, 351-359. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Protani, M., Coory, M. and Martin, J.H. (2010) Effect of Obesity on Survival of Women with Breast Cancer: Systematic Review and Meta-Analysis. Breast Cancer Research and Treatment, 123, 627-635. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Sestak, I., Distler, W., Forbes, J.F., Dowsett, M., Howell, A. and Cuzick, J. (2010) Effect of Body Mass Index on Recurrences in Tamoxifen and Anastrozole Treated Women: An Exploratory Analysis from the ATAC Trial. Journal of Clinical Oncology, 28, 3411-3415. [Google Scholar] [CrossRef]
|
|
[4]
|
Jemal, A., Bray, F., Center, M.M., et al. (2011) Global Cancer Statistics. CA: A Cancer Journal for Clinicians, 61, 69-90. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Phipps, A.I., Chlebowski, R.T., Pintice, R., et al. (2011) Reproductive History and Contraceptive Use in Relation to Risk of Triple-Negitive Breast Cancer. Journal of the National Cancer Institute, 103, 470-477. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Paton, R.J., Phillips, K.L., Jones, L.A., et al. (2012) Associations among Physical Activity, Body Mass Index, and Health-Related Quality of Life by Race/Ethnicity in a Diverse of Breast Cancer Survivors. Cancer, 118, 4024-4031. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Flegal, K.M., Carroll, M.D., Ogden, C.L., et al. (2010) Prevalence and Trends in Obesity among US Adults, 1999-2008. JAMA, 303, 235-241. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Nelson, L.R. and Bulun, S.E. (2001) Estroge Production and Action. Journal of the American Academy of Dermatology, 45, 116-124. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Moore, M.M., Chua, W., Chades, K.A., et al. (2010) Inflammation and Cancer: Causes and Consequences. Clin Pharmacology & Therapeutics, 87, 504-508. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Dossantos, E., Benaitreau, D., Dieudonne, M.N., et al. (2008) Adiponectin Mediates an Antiproliferative Response in Human MDA-MB 231 Breast Cancer Cells. Oncology Reports, 20, 971-977.
|
|
[11]
|
Taliaferro-Smith, L., Nagali, A., Zhong, D., et al. (2009) KLB1 Is Required for Adiponectin-Mediated Modulation of AMPK-s6K Axis and Inhibition of Migration and Invision of Breast Cancer Cells. Oneogene, 28, 2621-2633. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Dubois, V., Delon, L., Biuard, H., et al. (2013) Breast Cancer and Obesity: In Vitro Interferences between Adipokines and Proangiogenic Features and Antitumor Therapies? PLoS ONE.
|